CE Mark for New HyperView™ Product Announced by HyperMed Imaging, Inc.
4/2/18: European approval for groundbreaking imaging technology.
HyperMed Imaging Announces Cardiology Group as Early Adopter For Its New HyperView Product
Per the company, the HyperView System is FDA cleared, and it represents a new standard of performance when assessing tissue oxygenation and perfusion in patients with potential circulatory compromise.
